STOCK TITAN

Intersect Ent (XENT) Stock Price, News & Analysis

XENT NASDAQ

Company Description

Intersect Ent (NASDAQ: XENT) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $954.9M.

This page collects what Stock Titan holds for XENT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-
Performance 1 year
$954.9M

Latest News

Intersect Ent has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include management, earnings, acquisition, conferences. View all XENT news →

SEC Filings

No SEC filings available for XENT.

Financial Highlights

Revenue (latest FY)
Net Income (latest FY)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

XENT Company Profile & Sector Positioning

Intersect Ent (XENT) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing XENT often look at related companies in the same sector, including Inmode Ltd. (INMD), Iradimed Corp (IRMD), Tandem Diabetes (TNDM), Beta Bionics, Inc. (BBNX), and Establishment Labs Hldgs Inc (ESTA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate XENT's relative position within its industry.

Frequently Asked Questions

What is the market cap of Intersect Ent (XENT)?

The market cap of Intersect Ent (XENT) is approximately 954.9M. Learn more about what market capitalization means .